Topical Agents for the Treatment of Psoriasis,Past,Present and Future

Nathan AW Rose GL . Fatal iatrogenic Cushing's syndrome. Lancet 1979; 1:207

du Vivier A Stoughton RB . Tachyphylaxis to the action of topically applied corticosteroids. Arch Dermatol 1975; 111:581–583

Miller JJ Roling D Margolis D . Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasis. J Am Acad Dermatol 1999; 41:546–549

Lebwohl MG Tan MH Meador SL . Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas. J Am Acad Dermatol 2001; 44:77–82

Katz HI Prawer SE Medansky RS . Intermittent corticosteroid maintenance treatment of psoriasis: A double-blind multicenter trial of augmented betamethasone dipropionate ointment in a pulse dose treatment regimen. Dermatologica 1991; 183:269–314

Meola T Soter NA Lim HW . Are topical corticosteroids useful adjunctive therapy for the treatment of psoriasis with ultraviolet radiation? A review of the literature. Arch Dermatol 1991; 127: 1708–1713

van der Rhee HJ Tijssen JG Herrmann WA . Combined treatment of psoriasis with a new aromatic retinoid (Tigason) in low dosage orally and triamcinolone acetonide cream topically: A double-blind trial. Br J Dermatol 1980; 102:203–212

Finzi AF . Individualized short-course cyclosporin therapy in psoriasis. Br J Dermatol 1996; 135:31–34

Franz TJ Parsell DA Halualani RM . Betamethasone valerate foam 0.12%: A novel vehicle with enhanced delivery and efficacy. Int J of Dermatol 1999; 38:628–632

Harrison PV . Topical tacalcitol treatment for psoriasis. Hosp Med 2000; 61:402–405

Kowalzick L . Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis. Br J Dermatol 2001; 144: 21–25

Gerritsen MJ Rulo HF Vlijmen-Willems I . Topical treatment of psoriatic plaques with 1,25-dihydroxyvitamin D3: A cell biological study. Br J Dermatol 1993; 128:666–673

Reichrath J Perez A Muller SM . Topical calcitriol (1,25-dihydroxyvitamin D3) treatment of psoriasis: An immunohistological evaluation. Acta Derm Venereol 1997; 77:268–272

Kienbaum S Lehmann P Ruzicka T . Topical calcipotriol in the treatment of intertriginous psoriasis. Br J Dermatol 1996; 135: 647–650

Bourke JF Iqbal SJ Hutchinson PE . The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis. Clin Exp Dermatol 1997; 22:259–261

Kragballe K Gjertsen BT De Hoop D . Double-blind, right/ left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991; 337:193–196

Lebwohl M Siskin SB Epinette W . A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol 1996; 35:268–269

Bleiker TO Bourke JF Mumford R . Long-term outcome of severe chronic plaque psoriasis following treatment with high-dose topical calcipotriol. Br J Dermatol 1998; 139:285–286

Klaber MR Hutchinson PE Pedvis-Leftick A . Comparative effects of calcipotriol solution (50 micrograms/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis. Br J Dermatol 1994; 131:678–683

Tosti A Piraccini BM Cameli N . Calcipotriol ointment in nail psoriasis; a controlled double-blind comparison with betamethasone dipropionate and salicylic acid. Br J Dermatol 1998; 139:655–659

Piraccini BM Tosti A Iorizzo M . Pustular psoriasis of the nails: Treatment and long-term follow-up of 46 patients. Br J Dermatol 2001; 144:1000–1005

Speight EI Farr PM . Calcipotriol improves the response of psoriasis to PUV A. Br J Dermatol 1994; 130:79–82

van de Kerkhof PC Cambazard F Hutchinson PE . The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis. Br J Dermatol 1998; 138:84–89

Kokelj F Torsello P Plozzer C . Calcipotriol improves the efficacy of cyclosporine in the treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 1998; 10:143–146

Kragballe K . Combination of topical calcipotriol (MC 903) and UVB radiation for psoriasis vulgaris. Dermatologica 1990; 181: 211–214

Brands S Brakman M Bos JD . No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasis. J Am Acad Dermatol 1999; 41:991–995

Lebwohl M Hecker D Martinez J . Interactions between Calcipotriene and ultraviolet light. J Am Acad Dermatol 1997; 37:93–95

De Rie MA Di Nuzzo S Brands S . Calcipotriol ointment and cream or their vehicles applied immediately before irradiation inhibit ultraviolet B-induced erythema. Br J Dermatol 2000; 142:1160–1165

van Rossum MM van Erp PEJ van de Kerkhof PCM . Treatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: A flow cytometric study. Dermatology 2001; 203:148–152

Foster RH Brogden RN Benfield P . Tazarotene. Drugs 1998; 55:705–712

Duvic M Nagpal S Asano AT . Molecular mechanisms of tazarotene action in psoriasis. J Am Acad Dermatol 1997; 37: S18–S24

Weinstein GD Krueger GG Lowe NJ . Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. J Am Acad Dermatol 1997; 37:85–92

Krueger GG Drake LA Elias PM . The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis. Arch Dermatol 1998; 134:57–60

Persaud A Bershad S lamba S . (1998) Short contact tazarotene therapy for psoriasis. Poster presented at 59th annual meeting of American Academy of Dermatology, February 2001, Washington, DC.

Koo JY Lowe NJ Lew-Kaya DA . Tazarotene plus UVB phototherapy in the treatment of psoriasis. J Am Acad Dermatol 2000; 43:821–828

Behrens S Grundmann-Kollmann M Schiener R . Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel. J Am Acad Dermatol 2000; 42:493–495

Hecker D Worsley J Yueh G . Interactions between tazarotene and ultraviolet light. J Am Acad Dermatol 1999; 41:927–930

Ramsay B Lawrence CM Bruce JM . The effect of triethanolamine application on anthralin-induced inflammation and therapeutic effect in psoriasis. J Am Acad Dermatol 1990; 23:73–76

Gerritsen MJ Boezeman JB Elbers ME . Dithranol embedded in crystalline monoglycerides combined with phototherapy (UVB): A new approach in the treatment of psoriasis. Skin Pharmacol Appl Skin Physiol 1998; 11:133–139

Schmid MH Korting HC . Coal tar, pine tar and sulfonated shale oil preparations: Comparative activity, efficacy and safety. Dermatology 1996; 193:1–5

van Schooten FJ Moonen EJ Rhijnsburger E . Dermal uptake of polycyclic aromatic hydrocarbons after hairwash with coal-tar shampoo. Lancet 1994; 344:1505–1506

Jemec GBE Osterlind A . Cancer in patients treated with coal tar: A long-term follow up study. J Eur Acad Dermatol Venereol 1994;: 153–156

Pittelkow MR Perry HO Muller SA . Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study. Arch Dermatol 1981; 117:465–468

Stern RS Zierler S Parrish JA . Skin carcinoma in patients with psoriasis treated with topical tar and artificial ultraviolet radiation. Lancet 1980; 1:732–735

Zonneveld IM Rubins A Jablonska S . Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. Arch Dermatol 1998; 134:1101–1102

Remitz A Reitamo S Erkko P . Tacrolimus ointment improves psoriasis in a microplaque assay. Br J Dermatol 1999; 141:103–107

Yamamoto T Nishioka K . Topical tacrolimus is effective for facial lesions of psoriasis. Acta Derm Venereol 2000; 80:451

Wohlrab J Jahn K Plaetzer M . Topical application of mycophenolate mofetil in plaque-type psoriasis. Br J Dermatol 2001; 144:1263–1264

Geilen CC Mrowietz U . Lack of efficacy of topical mycophenolic acid in psoriasis vulgaris. J Am Acad Dermatol 2000; 42:837–840

Syed TA Hadi SM Qureshi LA . Management of psoriasis vulgaris with methotrexate 0.25% in a hydrophilic gel: A placebo-controlled, double-blind study J Cutan Med Surg 2001; 5:299–302

Robinson DJ de Bruijn HS van der Veen N . Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin. Photochem Photobiol 1999; 69:61–70